Ambulatory mammography

Diagnostic imaging
Number of report

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for mammography in ambulatory settings.

All procedure codes for different types of mammography will be provided in the analysis.

When fee for service payment model is used, all fees for available reimbursement codes will be provided.

When DRG payment model is used, reimbursement analysis will cover the following indications:

  • mammography in malignant neoplasm of breast
  • mammography in benign breast lesions

The only reimbursement within public / statutory health insurance systems is considered.

Policy analysis will include reimbursement decisions and health technology assessments mammography as diagnostic and screening method.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of equipment for ambulatory mammography include:

  • ADANI (Mammoscan)
  • Analogic Corporation (Digital Mammography)
  • ANKE (ASR-4000, ASR-3000)
  • Aurora (Aurora)
  • Allengers Medical (Fairy DR, Fairy, Venus)
  • BMI Biomedical International (Milady)
  • Canon (Artemis)
  • Carestream Health (Digital Mammography)
  • Delphinus Medical Technologies (SoftVue)
  • DMS-IMAGING (Serenys)
  • ECORAY (EXR-650)
  • Fujifilm (AMULET Innovality, AMULET, AMULET f / AMULET s)
  • GE Healthcare (Senographe Pristina)
  • General Medical Merate (Viola)
  • GENORAY (DMX-600, MX-600)
  • GMI General Medical (Lambda)
  • Hologic (3Dimensions, Selenia Dimensions)
  • ITALRAY (Mammograph, Mammograph FFDM)
  • Konica Minolta (Digital Mammography)
  • Landwind Medical (Luna)
  • MS Westfalia (GAIA)
  • Metaltronica (Helianthus C)
  • Micrima (Maria)
  • Panacea Medical (Lilac)
  • Perlove Medical (BTX-9800B, BTX-9800D, MEGA600)
  • Philips Healthcare (MicroDose SI)
  • Planmed (Planmed Clarity 3D, Planmed Clarity 2D, Planmed Sophie Classic S)
  • Radmir (Syma, Madis)
  • Shenzhen Angell Technology (Mammography-DM 158)
  • Siemens Healthcare (Mammomat Revelation, Mammomat Inspiration, Mammomat Fusion, Mammomat Select)
  • SternMed (Xenox)
  • Villa Sistemi Medicali (Melody III, Melody IIID, Melody IID TS)

Table of content is not available at the moment. Report is still ongoing.


Oct 2020

The revised EBM (German Uniform Evaluation Standard) catalog for ambulatory reimbursement in Germany came into force on October 1, 2020. MTRC has compiled the selection of the most significant changes, concerning In-vitro diagnostics, telemedicine and vacuum wounds therapy.

Read more


Sep 2020

In July 2020, the Austrian Institute for Health Technology Assessment (AIHTA) issued an updated report on the PET/PET-CT evidence for need-based planning in Austria.

Read more


May 2020

The German Society for Neurology (DGN) has released a new version of the S1 guideline "Diagnostics and therapy of neurogenic bladder disorders." It is valid until January 2025.

Read more


Nov 2019

In October 2019, the Agency for Health Quality and Assessment of Catalonia (AQuAS) has released an assessment report regarding the evaluation of Сerenkov luminescence image projection system for intraoperative evaluation of surgical margins in breast, prostate and gastrointestinal cancer. This new technology is expected to get an improvement in the effectiveness of oncological surgery and a reduction in costs.

Read more


Oct 2019

The German Research Foundation (DFG) has launched a new Artificial Intelligence (AI) imaging priority program "Radiomics: Next Generation Medical Imaging" (“Radiomics: Nächste Generation der medizinischen Bildgebung”). More than 8 million euros will flow into the program in the next three years. The program will be coordinated by the University Hospital Freiburg.

Read more


Oct 2019

MTRC has developed three reports on the key market access topics, including innovation funding, health technology assessment and funding frameworks for medical devices. These reports help to understand the relevance of these frameworks to certain types of medical technologies, including diagnostic imaging technologies. This post provides some key facts about the HTA, funding and innovation payment landscape for cardiovascular devices in Europe.

Read more


Aug 2019

The mini-HTA for internal emergency medicine ultrasound in patients with urgent medical conditions was released in July 2019 in Norway. The method was determined as efficient, safe, and was recommended to be introduced as part of the clinical routine in the hospital.

Read more


Jun 2019

The report presents a summary of reimbursement situation for mammography in ambulatory settings. All procedure codes for different types of mammography will be provided in the analysis. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more


May 2019

The HTA center of Swedish Västra Götaland region has published a report, which aimed to evaluate the effectiveness of EEG-based neurofeedback as a treatment for post-traumatic stress disorder (PTSD). It is uncertain whether the procedure compared with no or standard treatment reduces PTSD symptoms in adult patients. It is also uncertain whether the treatment results in any difference in suicidal thoughts, level of functioning, or medication use.

Read more


Dec 2018

Changes will be made in sixteen chapters of Nomenclature. In relation to medical technologies and in-vitro diagnostics, the most important changes include creation of new codes for ophthalmology, otorhinolaryngology, radiology, radiotherapy and nuclear medicine, clinical biology and genetic examinations.

Read more


Oct 2018

In October 2018, the Austrian HTA body, the Ludwig-Boltzmann Institue (LBI), published the update on the PET/PET-CT topic. The report was done together with the Berlin Technical University.

Read more


Jun 2018

At the beginning of June 2018, the Andalusian agency for health technology evaluation, AETSA, has published a meta-analysis on digital tomosynthesis in breast cancer.

Read more


Jun 2018

In May of 2018, the Federal Joint Committee (G-BA) approved two additional indications for application of PET/CT for management of malignant lymphomas for coverage within statutory health insurance. As the procedures were included into Directive for methods and examinations and Directive methods of the contract medical care, they are now reimbursed in both hospital and out-patient settings.

Read more


Oct 2017

New procedure codes will be created for stem cell procedures, extracorporeal techniques (including hemodialysis and CO2 removal), surgical interventions, including growth-controlling spinal correction, transposition of peripheral nerve, interventions on veins, and percutaneous image-guided procedures (including code for pressure measurement in coronary arteries and additional code for drug-eluting balloon). Classification will be enabled from January 1, 2018.

Read more


Jun 2017

In March 2017, G-BA approved two additional indications for application of PET/CT for management of neck and head tumors in hospital settings after reevaluation of evidence by IQWiG in 2016. New indications concern decision making about need for neck dissection and laryngoscopic biopsy.

Read more
(we accept only company emails)